Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors

This study has been withdrawn prior to enrollment.
(PI moving to Southern Illinois University to start new protocol)
Sponsor:
Information provided by (Responsible Party):
Jeffrey W. Cozzens, NorthShore University HealthSystem Research Institute
ClinicalTrials.gov Identifier:
NCT00977795
First received: September 15, 2009
Last updated: August 16, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: January 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)